Interleukin-22 Drives Endogenous Thymic Regeneration in Mice

被引:289
|
作者
Dudakov, Jarrod A. [1 ,2 ]
Hanash, Alan M. [3 ]
Jenq, Robert R. [3 ,4 ]
Young, Lauren F. [1 ]
Ghosh, Arnab [1 ]
Singer, Natalie V. [1 ]
West, Mallory L. [1 ]
Smith, Odette M. [1 ]
Holland, Amanda M. [1 ,5 ]
Tsai, Jennifer J. [1 ,5 ]
Boyd, Richard L. [2 ]
van den Brink, Marcel R. M. [1 ,3 ,4 ,5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA
[2] Monash Univ, Monash Immunol & Stem Cell Labs, Melbourne, Vic 3800, Australia
[3] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
[4] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA
[5] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10021 USA
基金
英国医学研究理事会;
关键词
INNATE LYMPHOID-CELLS; ROR-GAMMA-T; EPITHELIAL-CELLS; INDUCER CELLS; IL-22; SIGNALS; DIFFERENTIATION; RECONSTITUTION; INFLAMMATION; HOMEOSTASIS;
D O I
10.1126/science.1218004
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Endogenous thymic regeneration is a crucial function that allows for renewal of immune competence after stress, infection, or immunodepletion. However, the mechanisms governing this regeneration remain poorly understood. We detail such a mechanism, centered on interleukin-22 (IL-22) and triggered by the depletion of CD4(+)CD8(+) double-positive thymocytes. Intrathymic levels of IL-22 were increased after thymic insult, and thymic recovery was impaired in IL-22-deficient mice. IL-22, which signaled through thymic epithelial cells and promoted their proliferation and survival, was up-regulated by radio-resistant ROR gamma(t)(+)CCR6(+)NKp46(-) lymphoid tissue inducer cells after thymic injury in an IL-23-dependent manner. Administration of IL-22 enhanced thymic recovery after total body irradiation. These studies reveal mechanisms of endogenous thymic repair and offer innovative regenerative strategies for improving immune competence.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 50 条
  • [31] Interleukin-22 promotes tumor angiogenesis
    Protopsaltis, Nicholas J.
    Liang, Wei
    Nudleman, Eric
    Ferrara, Napoleone
    ANGIOGENESIS, 2019, 22 (02) : 311 - 323
  • [32] Is there an interaction between interleukin-10 and interleukin-22?
    Wolk, K
    Witte, E
    Reineke, U
    Witte, K
    Friedrich, M
    Sterry, W
    Asadullah, K
    Volk, HD
    Sabat, R
    GENES AND IMMUNITY, 2005, 6 (01) : 8 - 18
  • [33] Biological and pathological activities of interleukin-22
    Lanfranca, Mirna Perusina
    Lin, Yanwei
    Fang, Jingyuan
    Zou, Weiping
    Frankel, Timothy
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2016, 94 (05): : 523 - 534
  • [34] Interleukin-22 in alcoholic hepatitis and beyond
    Xiaogang Xiang
    Seonghwan Hwang
    Dechun Feng
    Vijay H. Shah
    Bin Gao
    Hepatology International, 2020, 14 : 667 - 676
  • [35] Lactobacillus delivery of bioactive interleukin-22
    Yin Lin
    Kasper Krogh-Andersen
    Lennart Hammarström
    Harold Marcotte
    Microbial Cell Factories, 16
  • [36] The role of interleukin-22 in pityriasis rosea
    Al Mokadem, S.
    Ghonemy, S.
    Zidan, A.
    Abd El Aleem, G.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2017, 42 (01) : 30 - 35
  • [37] Epithelial polarity is disrupted by interleukin-22
    Lebenheim, L.
    May, C.
    Munoz, M.
    Heimesaat, M. M.
    Siegmund, B.
    Schulzke, J. -D.
    Schumann, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S15 - S15
  • [38] Interleukin-22 promotes tumor angiogenesis
    Nicholas J. Protopsaltis
    Wei Liang
    Eric Nudleman
    Napoleone Ferrara
    Angiogenesis, 2019, 22 : 311 - 323
  • [39] Interleukin-22 and its crystal structure
    Pinto Nagem, Ronaldo Alves
    Ferreira Junior, Josii Ribamar
    Dumoutier, Laure
    Renauld, Jean-Christophe
    Polikarpov, Igor
    INTERLEUKINS, 2006, 74 : 77 - 103
  • [40] Targeting interleukin-22 for cancer therapy
    Markota, Anamarija
    Endres, Stefan
    Kobold, Sebastian
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (08) : 2012 - 2015